Trials / Completed
CompletedNCT00796614
Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder
A Phase IIb/III, Multi-centre, Double-blind, Randomised, Placebo-controlled, Dose Ranging Study of Tamsulosin Hydrochloride (Low, Medium and High Dose) as Treatment in Children With Neuropathic Bladder for Three Months
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 231 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 2 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
Aim of this study is to evaluate the efficacy and safety of a range of doses of tamsulosin hydrochloride as treatment in children with an elevated detrusor leak point pressure associated with a known neurological deficit
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tamsulosin hydrochloride | Oral |
| DRUG | Placebo | Oral |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-11-24
- Last updated
- 2015-10-29
- Results posted
- 2012-09-12
Locations
52 sites across 13 countries: United States, Belgium, Brazil, Germany, India, Italy, Mexico, Philippines, Russia, South Africa, South Korea, Spain, Ukraine
Source: ClinicalTrials.gov record NCT00796614. Inclusion in this directory is not an endorsement.